{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:11:06Z","timestamp":1790712666889,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1093\/carcin\/bgl200","type":"journal-article","created":{"date-parts":[[2006,10,21]],"date-time":"2006-10-21T00:13:23Z","timestamp":1161389603000},"page":"704-712","source":"Crossref","is-referenced-by-count":102,"title":["Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study"],"prefix":"10.1093","volume":"28","author":[{"given":"Mark P.","family":"Purdue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Grulich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Vajdic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Whitby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chanock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,3]]},"reference":[{"key":"key\n\t\t\t\t20170520222001_b1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002030-200001280-00008","article-title":"B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS","volume":"14","author":"Grulich","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170520222001_b2","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood.V85.7.1843.bloodjournal8571843","article-title":"Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome\u2014associated non-Hodgkin's lymphoma","volume":"85","author":"Yawetz","year":"1995","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520222001_b3","first-page":"979","article-title":"Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma","volume":"8","author":"Schroeder","year":"1999","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"key\n\t\t\t\t20170520222001_b4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.1993.11.6.1099","article-title":"Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy","volume":"11","author":"Pluda","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170520222001_b5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0609.1996.tb01390.x","article-title":"Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma","volume":"57","author":"Zinzani","year":"1996","journal-title":"Eur. J. Haematol."},{"key":"key\n\t\t\t\t20170520222001_b6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ajh.2830460227","article-title":"Increased levels of circulating interleukin-6 in patients with newly diagnosed non-Hodgkin's lymphomas","volume":"46","author":"Stasi","year":"1994","journal-title":"Am. J. Hematol."},{"key":"key\n\t\t\t\t20170520222001_b7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2141.1994.tb05116.x","article-title":"Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma","volume":"88","author":"Stasi","year":"1994","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520222001_b8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/10428199809057568","article-title":"High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma","volume":"30","author":"Fayad","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"key\n\t\t\t\t20170520222001_b9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/10428199509049776","article-title":"Clinical significance of serial measurement of the serum levels of soluble interleukin-2 receptor and soluble CD8 in malignant lymphoma","volume":"16","author":"Motokura","year":"1995","journal-title":"Leuk. Lymphoma"},{"key":"key\n\t\t\t\t20170520222001_b10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","article-title":"Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients","volume":"15","author":"Bastion","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170520222001_b11","first-page":"CR75","article-title":"The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma","volume":"11","author":"Elahi","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"key\n\t\t\t\t20170520222001_b12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hon.2900120104","article-title":"Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level","volume":"12","author":"Parker","year":"1994","journal-title":"Hematol. Oncol."},{"key":"key\n\t\t\t\t20170520222001_b13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1365-2141.1996.5181059.x","article-title":"Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients","volume":"93","author":"Salles","year":"1996","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520222001_b14","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170520222001_b15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur. J. Immunogenet."},{"key":"key\n\t\t\t\t20170520222001_b16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/00007890-200110270-00019","article-title":"Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3\/CD28-stimulated peripheral blood lymphocytes","volume":"72","author":"Hoffmann","year":"2001","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20170520222001_b17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s002620050483","article-title":"A review of the association between interleukin-10 and human B-cell malignancies","volume":"46","author":"Khatri","year":"1998","journal-title":"Cancer Immunol. Immunother."},{"key":"key\n\t\t\t\t20170520222001_b18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"key\n\t\t\t\t20170520222001_b19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1359-6101(01)00020-X","article-title":"Tumor necrosis factor or tumor promoting factor?","volume":"13","author":"Balkwill","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"key\n\t\t\t\t20170520222001_b20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.191.1.89","article-title":"Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype","volume":"191","author":"Korner","year":"2000","journal-title":"J. Exp. Med."},{"key":"key\n\t\t\t\t20170520222001_b21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4049\/jimmunol.172.2.812","article-title":"TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma","volume":"172","author":"Batten","year":"2004","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170520222001_b22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.leu.2403244","article-title":"Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma","volume":"18","author":"Czarneski","year":"2004","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170520222001_b23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol."},{"key":"key\n\t\t\t\t20170520222001_b24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ijc.20128","article-title":"Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma","volume":"110","author":"Hughes","year":"2004","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170520222001_b25","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"key\n\t\t\t\t20170520222001_b26","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/1055-9965.EPI-05-0358","article-title":"WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studies","volume":"14","author":"Turner","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"key\n\t\t\t\t20170520222001_b27","doi-asserted-by":"crossref","first-page":"D617","DOI":"10.1093\/nar\/gkj151","article-title":"SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes","volume":"34","author":"Packer","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170520222001_b28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"key\n\t\t\t\t20170520222001_b29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc. B"},{"key":"key\n\t\t\t\t20170520222001_b30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jnci\/djh075","article-title":"Assessing the probability that a positive report is false: an approach for molecular epidemiology studies","volume":"96","author":"Wacholder","year":"2004","journal-title":"J. Natl Cancer Inst."},{"key":"key\n\t\t\t\t20170520222001_b31","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.166.6.3915","article-title":"Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus","volume":"166","author":"Gibson","year":"2001","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170520222001_b32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1521-6616(03)00214-6","article-title":"Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter \u2212592 C\/C genotype","volume":"109","author":"Breen","year":"2003","journal-title":"Clin. Immunol."},{"key":"key\n\t\t\t\t20170520222001_b33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2006.06030.x","article-title":"Association between non-Hodgkin lymphoma and haplotypes in the TNF region","volume":"133","author":"Spink","year":"2006","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520222001_b34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ijc.20199","article-title":"Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma","volume":"110","author":"Wu","year":"2004","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170520222001_b35","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1158\/0008-5472.CAN-06-0324","article-title":"Common genetic variants in pro-inflammatory and other immunoregulatory genes and the risk for non-Hodgkin lymphoma","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520222001_b36","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2005-10-4160","article-title":"Cytokine polymorphisms in the Th1\/Th2 pathway and susceptibility to non-Hodgkin lymphoma","volume":"107","author":"Lan","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520222001_b37","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1572-0241.2005.00338.x","article-title":"A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma","volume":"100","author":"Hellmig","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"key\n\t\t\t\t20170520222001_b38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/hmg\/11.11.1281","article-title":"Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors","volume":"11","author":"van Heel","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170520222001_b39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1399-0039.1998.tb03056.x","article-title":"Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter","volume":"52","author":"Uglialoro","year":"1998","journal-title":"Tissue Antigens"},{"key":"key\n\t\t\t\t20170520222001_b40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.gene.6363747","article-title":"Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals","volume":"2","author":"Kaijzel","year":"2001","journal-title":"Genes Immun."},{"key":"key\n\t\t\t\t20170520222001_b41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1399-0039.1998.tb03002.x","article-title":"Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese","volume":"51","author":"Higuchi","year":"1998","journal-title":"Tissue Antigens"},{"key":"key\n\t\t\t\t20170520222001_b42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1034\/j.1600-051X.2003.00287.x","article-title":"Tumor necrosis factor-alpha gene (TNF-alpha) \u22121031\/-863, \u2212857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese","volume":"30","author":"Soga","year":"2003","journal-title":"J. Clin. Periodontol."},{"key":"key\n\t\t\t\t20170520222001_b43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/00365520310002508","article-title":"Association of TNF-alpha-857C with inflammatory bowel disease in the Australian population","volume":"38","author":"O'Callaghan","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"key":"key\n\t\t\t\t20170520222001_b44","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1128\/MCB.20.24.9113-9119.2000","article-title":"Functional consequences of a polymorphism affecting NF-kappaB p50\u2013p50 binding to the TNF promoter region","volume":"20","author":"Udalova","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"key\n\t\t\t\t20170520222001_b45","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/hmg\/8.8.1443","article-title":"A common functional polymorphism (C\u2014>A substitution at position \u2212863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha","volume":"8","author":"Skoog","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170520222001_b46","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1200\/JCO.2003.05.013","article-title":"Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma","volume":"21","author":"Weng","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170520222001_b47","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/01.CIR.101.24.2783","article-title":"Association of a T29\u2014>C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese","volume":"101","author":"Yokota","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170520222001_b48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/hmg\/8.1.93","article-title":"Genetic control of the circulating concentration of transforming growth factor type beta1","volume":"8","author":"Grainger","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170520222001_b49","first-page":"2610","article-title":"A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer","volume":"63","author":"Dunning","year":"2003","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520222001_b50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng1001-117","article-title":"TGF-beta signaling in tumor suppression and cancer progression","volume":"29","author":"Derynck","year":"2001","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170520222001_b51","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1158\/1055-9965.EPI-05-0463","article-title":"Genetic variation and willingness to participate in epidemiologic research: data from three studies","volume":"14","author":"Bhatti","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/28\/3\/704\/17285552\/bgl200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:02:16Z","timestamp":1736614936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgl200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,3]]},"published-print":{"date-parts":[[2007,3]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgl200","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}